Canada Markets closed

Sirona Biochem Corp. (SBM.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.23000.0000 (0.00%)
At close: 03:31PM EDT

Sirona Biochem Corp.

595 Burrard Street
Vancouver, BC V7X 1L4
Canada

https://www.sironabiochem.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. Howard J. Verrico M.D., Ph.D.Founder, Chairman, CEO & Sec.161.28kN/A1961
Mr. Christopher D. Hopton C.G.A., CPACFO & Director147.84kN/A1966
Dr. Géraldine Deliencourt-Godefroy Ph.D.Chief Scientific Officer & Director213.39kN/AN/A
Ms. Michelle Seltenrich MBAVP of OperationsN/AN/AN/A
Dr. Brett A. Premack Ph.D.Scientific ConsultantN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects include the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.

Corporate Governance

Sirona Biochem Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.